With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:
Coles Group Ltd (ASX: COL)
According to a note out of Citi, its analysts have retained their buy rating and $20.20 price target on this supermarket operator's shares. This follows the release of a quarterly update from Coles last week, which came in a touch ahead of Citi's forecasts. The broker believes that the company's private label offering has been a key driver of this outperformance and appears to believe the trend can continue. The Coles share price is fetching $18.29 this afternoon.
Coronado Global Resources Inc (ASX: CRN)
A note out of Goldman Sachs reveals that its analysts have retained their buy rating on this coal miner's shares with an increased price target of $2.20. This follows the release of a quarterly update that was in-line with expectations. Goldman continues to see Coronado as a great option due to its strong free cash flow and dividend yield, as well as a supportive met coal market on supply risks and China's reopening. The Coronado Global share price is trading at $1.68 today.
ResMed Inc. (ASX: RMD)
Analysts at Goldman Sachs have also retained their buy rating on this sleep treatment company's shares with an improved price target of $39.60. This follows the release of a solid quarterly update from ResMed last week. Goldman was pleased with what it saw and has upgraded its revenue and earnings estimates through to FY 2026. The broker also continues to see a long-duration runway of HSD organic growth and highlights that its shares trade on lower than normal multiples. The ResMed share price is trading at $35.84 on Monday.
